Target intelligence / Profile preview

Enoyl-acyl carrier protein reductase FabK (FabK)

Target
FabK
Molecular classification
Enzyme, Flavoprotein, FMN-dependent oxidoreductase, Member of the TIM barrel (triosephosphate isomerase barrel) structural family
01

Overview

Enoyl-acyl carrier protein reductase FabK is a flavoprotein enzyme found in certain bacterial fatty acid synthesis pathways (type II FAS). Unlike other enoyl-ACP reductases (FabI, FabL, FabV), FabK features a TIM barrel structure and utilizes flavin mononucleotide (FMN) as a cofactor, with NADH serving as a reductant. FabK catalyzes the reduction of enoyl-ACP substrates during fatty acid elongation via a ping-pong bi-bi mechanism that involves indirect hydride transfer from NADH to the substrate through FMN. Its activity is sensitive to monovalent cation salts and displays some NADH oxidase activity, even without substrate. FabK is present in pathogens such as Streptococcus pneumoniae, Enterococcus faecalis, Listeria monocytogenes, and Porphyromonas gingivalis, where it contributes to cell membrane synthesis and survival. Due to FabK's essential role in bacterial physiology and its structural divergence from human enzymes, it represents a promising target for the development of new antibacterial agents, especially given growing resistance to existing fatty acid synthesis inhibitors.

Other names
FabKEnoyl-ACP reductase II (sometimes specified as type II)Enoyl-acyl carrier protein reductase KFlavin-dependent enoyl-ACP reductase
02

Mechanism of action

Competitive or noncompetitive inhibition of FMN cofactor or substrate binding site, leading to blocked fatty acid biosynthesis and bacterial cell death

03

Biological functions

Fatty acid biosynthesis (terminal reduction step in the elongation cycle)NADH/NAD(P)H oxidation (in presence and absence of substrate)
04

Disease associations

Infection (critical in bacteria such as Streptococcus pneumoniae, Listeria monocytogenes, Enterococcus faecalis, Porphyromonas gingivalis)
05

Safety considerations

FabK is absent in humans, suggesting low risk of off-target human toxicity; however, selectivity against similar human flavoproteins must be confirmed for new drugs.Potential for bacterial resistance via mutations affecting expression or amino acid sequence of FabK
06

Interacting drugs

There are no clinically approved drugs directly targeting FabK as of 2024, but it is investigated as a potential target for antibacterial compounds. Known inhibitors studied in vitro include some flavin-targeted molecules; FabI inhibitors (such as AFN-1252) do not inhibit FabK.
07

Biomarkers

Expression of the fabK gene/protein in bacterial pathogens as a marker for susceptibility to FabK-targeted antibacterial compoundsBacterial growth phenotype in response to FabK inhibition or mutation

Beyond the preview

Go deeper on Enoyl-acyl carrier protein reductase FabK (FabK).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Enoyl-acyl carrier protein reductase FabK (FabK).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call